Andrianov Alexander Mikhailovich

Publications in Math-Net.Ru

1. Application of virtual screening and molecular modeling technologies to identify potential SARS-CoV-2 main protease inhibitors
   
   Mat. Biolog. Bioinform., 18:1 (2023),  15–32
2. Development of a deep learning generative neural network for computer-aided design of potential SARS-Cov-2 inhibitors
   
   Mat. Biolog. Bioinform., 17:2 (2022),  188–207
3. Design and identification of potential HIV-1 entry inhibitors using In silico click chemistry and molecular modeling methods
   
   Mat. Biolog. Bioinform., 16:2 (2021),  317–334
4. Rational design of potential Bcr-Abl tyrosine kinase inhibitors by the methods of molecular modeling
   
   Mat. Biolog. Bioinform., 15:2 (2020),  396–415
5. In silico identification of high-affinity ligands of the HIV-1 gp120 protein, potential peptidomimetics of neutralizing antibody N6
   
   Mat. Biolog. Bioinform., 14:2 (2019),  430–449
6. Development of potential HIV-1 inhibitors by in silico click chemistry and molecular modeling methods
   
   Mat. Biolog. Bioinform., 13:2 (2018),  507–525
7. Molecular modeling of novel non-steroidal aromatase inhibitors containing 1,2,4-triazole
   
   Mat. Biolog. Bioinform., 13:1 (2018),  290–307
8. Identification of novel potential inhibitors of the HIV-1 gp41 protein by virtual screening and molecular modeling methods
   
   Mat. Biolog. Bioinform., 10:2 (2015),  325–343
9. Virtual Screening of Novel Hiv-1 Entry Inhibitors Blocking Cd4-Binding Site of the Virus Envelope Gp120 Protein
   
   Mat. Biolog. Bioinform., 9:2 (2014),  359–372
10. Computer-Aided Design of Novel HIV-1 Entry Inhibitors Based on Glycosphingolipids
    
    Mat. Biolog. Bioinform., 8:1 (2013),  258–275
11. Computer-Aided Search for Novel Anti-Hiv-1 Agents Presenting Peptidomimetics of Neutralizing Antibodies and Evaluation of their Potential Inhibitory Activity by Molecular Modeling
    
    Mat. Biolog. Bioinform., 8:1 (2013),  119–134
12. Determination of the invariant structural elements for the third variable domain of the HIV-1 gp120 protein by molecular modeling
    
    Mat. Biolog. Bioinform., 6:2 (2011),  298–311
13. Computer-aided design of the potential drugs for AIDS therapy: $\beta$-galactosylceramide and the HIV-1 gp120 V3 Loop
    
    Mat. Biolog. Bioinform., 6:2 (2011),  161–172